Chlorpropamide

ANDA 88726, held by Rising. Chlorpropamide.

As of Nov 13, 2026, ANDA 88726 (Chlorpropamide), held by Rising, was first approved by FDA on Aug 31, 1984, with 7 approved supplements and 0 published complete response letters.

First approved: Aug 31, 1984
Supplements approved: 7
Complete response letters: 0

Approvals and New Uses

The original application and every efficacy supplement, newest first; all 8 submissions below

Date	Submission	Status	Documents
Aug 31, 1984	Original application	Approved	None posted

Products

1 strengths and forms

Product	Active ingredient	Marketing
Chlorpropamide250MG · tablet;oral	Chlorpropamide	Discontinued

All 8 submissions, including labeling and manufacturing supplements

Date	Submission	Status	Documents
Dec 30, 1994	Supplement 15Manufacturing	Approved	None posted
Jan 27, 1988	Supplement 13Labeling	Approved	None posted
Aug 8, 1986	Supplement 7Manufacturing	Approved	None posted
Aug 8, 1986	Supplement 6Manufacturing	Approved	None posted
Aug 8, 1986	Supplement 5Manufacturing	Approved	None posted
Mar 13, 1986	Supplement 4Manufacturing	Approved	None posted
Sep 24, 1985	Supplement 2Manufacturing	Approved	None posted
Aug 31, 1984	Original application	Approved	None posted

Identifiers

Application: ANDA 88726
Drugs@FDA: Overview at FDA
Company: Rising Pharmaceuticals

Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters